Abstract: Imidazophenanthridine ligands and metal complexes are provided. The compounds exhibit improved stability through a linking substitution that links a nitrogen bonded carbon of an imidizole ring to a carbon on the adjacent fused aryl ring. The compounds may be used in organic light emitting devices, particularly as emissive dopants, providing devices with improved efficiency, stability, and manufacturing. In particular, the compounds provided herein may be used in blue devices having high efficiency.

Abstract: A novel type of blue emitter is described based on the azaphenanthridine imidazole ligand. The preferred use of this moiety for generating blue phosphorescence is as part of a symmetric platinum tetradentate complex.

Abstract: A compound including a ligand having the formula: is disclosed. In these formulas, each R1, R2, and R3 is independently selected from hydrogen, alkyl, and aryl; at least one of R1 and R2 is a branched alkyl containing at least 4 carbon atoms, where the branching occurs at a position further than the benzylic position; where R1 and R3 are mono-, di-, tri-, tetra-, or no substitutions; and R2 is mono-, di-, or no substitutions. Heteroleptic iridium complexes including such compounds, and devices including such compounds are also disclosed.

Abstract: A new class of blue emissive complexes are described. The compounds comprise pyridyl benzimidazole ligands with twisted aryl groups for improved color.

Abstract: Compounds having the structure of Formula M(LA)x(LB)y and Formula III, are disclosed. In Formula M(LA)x(LB)y, Ligand LA is and ligand LB is a mono anionic bidentate ligand. In these compounds, metal M has an atomic number greater than 40; x is 1, 2, or 3; y is 0, 1, or 2; x+y is the oxidation state of metal M; L11 represents a linking group selected from alkyl, cycloalkyl, aryl, and heteroaryl; L12 represents a linking group selected from NR15 and PR15; each R1, R2, R3, R4, R5, R6, R11, R12, R13, R14, and R15 is independently selected from a group of substituents, wherein any adjacent substituents are optionally joined to form a fused or unfused ring; and LA and LB are optionally joined to form a ligand that is at least tetradentate. Formulations and devices, such as OLEDs, that include the compound of Formula M(LA)x(LB)y are also described.

Abstract: This invention discloses novel metal complexes for phosphorescent OLEDs. The incorporation of a specific nitrogen substitution in the benzimidazole phenanthridine ligand system is shown to provide desirable color.

Abstract: Homoleptic organometallic iridium complexes formed from bidentate substitute phenylpyridine ligands are disclosed. Devices containing the homoleptic organometallic iridium complexes that exhibit improved device manufacturing, fabrication, stability, efficiency, and/or color are also disclosed.

Abstract: Multidentate metal complexes useful as phosphorescent emitters in display and lighting applications have the structures as described herein. Multidentate metal complexes and compositions including one or more of the complexes described herein can be useful as emitters in organic light emitting diodes (OLEDs), displays and lighting applications, and photovoltaic devices. Generally, a chemical structural change will affect the electronic structure of the compounds, which thereby affects the optical properties of the compounds (e.g., emission and absorption spectra). Thus, the compounds described herein can be tailored or tuned to a particular emission or absorption energy. In some aspects, the optical properties of the compounds disclosed herein can be tuned by varying the structure of the ligand surrounding the metal center.

Abstract: Novel phosphorescent tetradentate platinum compounds of Formula I are provided. The complexes contain a dibenzo moiety, which allows for the creation of OLED devices with improved properties when compounds of Formula I are incorporated into such devices. Compounds of Formula I? that comprise two ligands that contain a 5-membered carbocyclic or heterocyclic ring, one of which contains an imidazole ring with a twisted aryl group attached to N?1 and a second aromatic ring that is attached to the platinum via a carbon atom. These compounds may be advantageously used in OLEDs.

Abstract: A compound having a structure of Formula M(LA)x(LB)y(LC)z, where ligand LA is ligand LB is and ligand LC is is disclosed. In Formula M(LA)x(LB)y(LC)z, M is a metal having an atomic number greater than 40; x is 1, 2, or 3; y and z are 0, 1, or 2; x+y+z is the oxidation state of metal M; Z1-Z6 are each C or N; ZD is N or a carbene carbon; rings C and D are independently a 5 or 6-membered carbocyclic or heterocyclic ring; R4 is substituted, while each of R1, R2, R3, RC, RD, R11, R12, and R13 are selected from hydrogen and a variety of moieties; and any adjacent substituents of R1, R2, R3, R4, RC, RD, R11, R12, and R13 are optionally joined to form a ring. Formulations and devices, such as an OLEDs, that include the compound of formula M(LA)x(LB)y(LC)z are also described.

Abstract: A novel type of blue emitter is described based on the azaphenanthridine imidazole ligand. The preferred use of this moiety for generating blue phosphorescence is as part of a symmetric platinum tetradentate complex.

Abstract: Multidentate metal complexes useful as phosphorescent emitters in display and lighting applications having the following structures:

Abstract: Machine, methods, and computer program encoded on non-transitory memory for facilitating electronic inventory tracking and management of products through messaging over an existing financial services payment network are provided. An example includes an inventory management computer in communication with a merchant POS apparatus or terminal over an existing financial services payment network and configured to receive and process purchase transaction data associated with a product being purchased. The computer can also include, for example, electronic inventory management computer program configured to perform various operations including generating product identifiers, forming product look up tables to correlate the identifiers with the products, and providing inventory data to product providers.

Abstract: Novel phosphorescent tetradentate platinum compounds of Formula I are provided. The complexes contain a dibenzo moiety, which allows for the creation of OLED devices with improved properties when compounds of Formula I are incorporated into such devices. Compounds of Formula I? that comprise two ligands that contain a 5-membered carbocyclic or heterocyclic ring, one of which contains an imidazole ring with a twisted aryl group attached to N?1 and a second aromatic ring that is attached to the platinum via a carbon atom. These compounds may be advantageously used in OLEDs.

Abstract: Embodiments of systems, computer program product, and related computer implemented methods to issue a closed-loop retail prepaid card including a user-designed external face using a chit, the chit being defined by an identification mechanism representing a financial commitment to issue a closed-loop retail prepaid card in an amount associated with a value paid for the chit, are provided. Embodiments of the present invention advantageously provide a service that enables a consumer to purchase, at the storefront of a retail establishment, a chit card that the consumer can subsequently redeem through a graphical user interface of an Internet website for a closed-loop retail prepaid card with a user-designed external face. The user-designed closed-loop retail prepaid card, for example, can be subsequently printed and delivered to an intended recipient. Advantageously, such a service can be made available to any retail establishment that uses a point-of-sale system.

Abstract: Novel phosphorescent tetradentate platinum compounds of Formula I are provided. The complexes contain a dibenzo moiety, which allows for the creation of OLED devices with improved properties when compounds of Formula I are incorporated into such devices. Compounds of Formula I? that comprise two ligands that contain a 5-membered carbocyclic or heterocyclic ring, one of which contains an imidazole ring with a twisted aryl group attached to N?1 and a second aromatic ring that is attached to the platinum via a carbon atom. These compounds may be advantageously used in OLEDs.

Abstract: Host materials with pentafluorophenyl substitution are described. These compounds are designed for, and used for hosting aza substituted dopants that may be susceptible to intramolecular deprotonation. In addition, the fluorinated substitution aids with electron transport within the emissive layer.

Abstract: A compound having the structure of Formula I is disclosed. In the structure of Formula I, each of R1, R2, and R3 is independently a hydrogen, a non-fused aryl group having one meta-substituent, or a non-fused heteroaryl six-membered ring having one or more meta-substituents; each meta-substituent is a non-fused aryl or non-fused heteroaryl six-membered ring optionally substituted with further substituents selected from the group consisting of non-fused aryl groups, non-fused heteroaryl groups, and alkyl groups; and at least one of R1, R2, and R3 is a non-fused aryl having one meta-substituent or a heteroaryl six-membered ring having at least one meta-substituent, wherein each meta-substituent is a non-fused aryl or non-fused heteroaryl group further substituted with a chain of at least two non-fused aryl or non-fused heteroaryl groups. The compounds may be useful in phosphorescent organic light emitting devices.

Abstract: Novel electroluminescent devices containing bicarbazole triazine compounds as emissive dopants are described. Devices incorporating this class of compounds exhibit delayed fluorescence characteristics that showed EQE's far exceeding the theoretical limit for a conventional fluorescent device.

Abstract: A power system for a medical cart includes a power supply, a direct current power bus electrically coupled to the power supply, and an electrical output power module electrically coupled to the direct current power bus. The power supply is positioned within the base of the medical cart and outputs direct current electrical power. The direct current power bus is the support of the medical cart, with the base being at one end of the support. The electrical output power module is within the work platform of the medical cart at the other end of the support. The electrical output power module inputs the direct current electrical power from the direct current power bus, and converts the input direct current electrical power to an electrical power output having a different state.